Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Remegen (9995 HK)
Watchlist
178
Analysis
Health Care
•
China
RemeGen Co., Ltd. operates biotechnology businesses. The Company develops therapeutic antibody drugs such as antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and double antibodies. RemeGen provides solutions autoimmune diseases, tumor diseases, and ophthalmic diseases.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
26 Apr 2024 20:38
(1) Revision Of Annual Cap Under The 2023-2025 Mabplex Master Service Agreement (2) Revision Of Annual Caps Under The 2023-2025 Materials Purchase Framework Agreement
Attachment
Exchange Announcement •
26 Apr 2024 20:31
2024 First Quarterly Report
Attachment
Exchange Announcement •
26 Apr 2024 17:08
2023 Environmental, Social And Governance Report
Attachment
Exchange Announcement •
26 Apr 2024 16:57
2023 Annual Report
Attachment
Exchange Announcement •
16 Apr 2024 16:30
Date Of Board Meeting
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.1
x